Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20344)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Primary Target | Pathway | GR50 | GRmax | GR_AOC | Death_AUC | GR Hill Coefficient | GEC50 | GR r2 |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Cediranib | VEGFR/cKIT | RTK | 9.6397 | 0.4781 | 0.0310 | 0.0012 | 3.3546 | 8.1 | 0.99825 |
MCF 10A | Cabozantinib | VEGFR2/MET | RTK | 25.9104 | 0.8434 | -0.0114 | 0.0040 | 4.9998 | 11.7694 | 0.81226 |
MCF7 | Abemaciclib | CDK4/6 | Cell cycle | 0.023572 | -0.2684 | 0.7018 | 0.0913 | 0.3795 | 0.13917 | 0.95433 |
MCF7 | Palbociclib | CDK4/6 | Cell cycle | 0.074952 | 0.2542 | 0.3461 | 0.0139 | 1.0473 | 0.035667 | 0.99237 |
MCF7 | AZD7762 | CHK1/2 | Cell cycle | 0.04144 | -0.1856 | 0.5977 | 0.1318 | 0.8993 | 0.048851 | 0.95892 |
MCF7 | Volasertib | PLK | Cell cycle | 0.0028671 | -0.0338 | 0.6070 | 0.1245 | 4.2176 | 0.002824 | 0.99423 |
MCF7 | Dinaciclib | pan CDK | Cell cycle | 0.0083068 | -0.2493 | 0.6441 | 0.1256 | 3.5461 | 0.009348 | 0.9995 |
MCF7 | Cisplatin | Chemo | Chemotherapy | 9.3237 | 0.4749 | 0.0631 | 0.0037 | 1.0987 | 15.5357 | 0.99433 |
MCF7 | Doxorubicin | Chemo | Chemotherapy | 0.016105 | -0.2856 | 0.6363 | 0.1012 | 0.9326 | 0.024539 | 0.97476 |
MCF7 | Taxol | Chemo | Chemotherapy | 0.0013771 | -0.1059 | 0.7722 | 0.1589 | 1.1560 | 0.0016261 | 0.94939 |
MCF7 | Topotecan | Topo I | Chemotherapy | 0.0060429 | -0.2711 | 0.8540 | 0.1220 | 1.1751 | 0.0071167 | 0.95657 |
MCF7 | Etoposide | Topo II | Chemotherapy | 0.13489 | -0.0441 | 0.4992 | 0.0261 | 1.3301 | 0.14783 | 0.99669 |
MCF7 | Dasatinib | BCR/ABL | MAPK/nRTK | 0.069398 | 0.1574 | 0.4829 | 0.0400 | 1.6265 | 0.055227 | 0.99565 |
MCF7 | Trametinib | MEK | MAPK/nRTK | Inf | 0.5581 | 0.2767 | 0.0114 | 1.2083 | 0.0027903 | 0.99413 |
MCF7 | Saracatinib | SRC | MAPK/nRTK | 0.57707 | 0.2735 | 0.3223 | 0.0241 | 0.6671 | 0.25342 | 0.9907 |
MCF7 | ABT-737 | Bcl2/XL | Misc | 22.5968 | 0.7267 | 0.0146 | 0.0115 | 1.1080 | 29.1513 | 0.88699 |
MCF7 | Vorinostat | HDAC | Misc | 0.54198 | -0.1752 | 0.3494 | 0.0792 | 1.1946 | 0.72813 | 0.99735 |
MCF7 | Luminespib | HSP90 | Misc | 0.0087135 | 0.0015 | 0.5132 | 0.0620 | 2.7505 | 0.008705 | 0.99839 |
MCF7 | A-1210477 | Mcl-1 | Misc | Inf | 0.8774 | -0.0002 | 0.0007 | 1.8795 | 11.2338 | 0.74456 |
MCF7 | Olaparib | PARP | Misc | 10.3196 | 0.5137 | 0.0554 | 0.0074 | 1.4485 | 14.0349 | 0.99551 |
MCF7 | Bleomycin | Radiation | Misc | 0.07723 | -0.0459 | 0.5554 | 0.0443 | 1.2323 | 0.083522 | 0.99888 |
MCF7 | Ipatasertib | AKT | PI3K/mTOR | 1.2964 | 0.2497 | 0.2597 | 0.0350 | 0.6498 | 0.91468 | 0.99756 |
MCF7 | Alpelisib | PI3Ka | PI3K/mTOR | 0.58502 | 0.0207 | 0.3259 | 0.0518 | 0.6552 | 0.82437 | 0.98733 |
MCF7 | Taselisib | PI3Ka, g, d | PI3K/mTOR | 0.0083619 | -0.2545 | 0.7677 | 0.1823 | 0.5107 | 0.014367 | 0.95432 |
MCF7 | TGX221 | PI3Kb | PI3K/mTOR | 15.3151 | 0.7893 | -0.0068 | 0.0019 | 3.9246 | 12.6094 | 0.85557 |